ATC/DDD

ATC/DDD index V09IX

You are here: Home > ATC/DDD > V > V09 > V09I

- ATC/DDD
Anatomical therapeutic chemical (ATC) classification system
- V
VARIOUS
- V09
DIAGNOSTIC RADIOPHARMACEUTICALS
- V09I
TUMOUR DETECTION

V09IX

Other diagnostic radiopharmaceuticals for tumour detection

ATC/DDD code V09IX for Other diagnostic radiopharmaceuticals for tumour detection

Gallium-citrate used for non-specific tumour localisation is classified in V09H - Inflammation and infection detection. Thallium-chloride used for tumour detection is classified in V09G -Cardiovascular system.

Iobenguane (131I) in low dose is classified here while high dose for therapy is classified in V10X -Other therapeutic radiopharmaceuticals.

V09IX01
Iobenguane (123I)
V09IX02
Iobenguane (131I)
V09IX03
Iodine (125I) CC49-monoclonal antibody
V09IX04
Fludeoxyglucose
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us